XILINX, INC. | |||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||
(In thousands) | |||
|
| December 28, 2019 |
| March 30, 2019 * |
|
| (unaudited) |
|
|
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash, cash equivalents and short-term investments | $ 2,425,165 |
| $ 3,175,684 |
Accounts receivable, net | 253,548 |
| 335,165 |
Inventories | 328,209 |
| 315,358 |
Other current assets | 121,099 |
| 65,771 |
Total current assets | 3,128,021 |
| 3,891,978 |
Net property, plant and equipment | 378,242 |
| 328,929 |
Long-term investments | - |
| 53,433 |
Other assets | 1,444,959 |
| 877,008 |
Total Assets | $ 4,951,222 |
| $ 5,151,348 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued liabilities | $ 515,880 |
| $ 475,036 |
Long-term debt | 1,246,000 |
| 1,234,807 |
Other long-term liabilities | 548,180 |
| 579,996 |
Stockholders' equity | 2,641,162 |
| 2,861,509 |
Total Liabilities and Stockholders' Equity | $ 4,951,222 |
| $ 5,151,348 |
|
| |
*Fiscal 2019 balances are derived from audited financial statements. |
XILINX, INC. | |||||||||
SUPPLEMENTAL FINANCIAL INFORMATION | |||||||||
(Unaudited) | |||||||||
(In thousands) | |||||||||
|
| Three Months Ended |
| Nine Months Ended | ||||||
|
| December 28, 2019 |
| September 28, 2019 |
| December 29, 2018 |
| December 28, 2019 |
| December 29, 2018 |
SELECTED CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
|
Depreciation and amortization of software | $ 26,311 |
| $ 22,438 |
| $ 17,974 |
| $ 68,882 |
| $ 49,097 |
| Amortization - others | 15,276 |
| 12,965 |
| 7,984 |
| 37,326 |
| 23,461 |
| Stock-based compensation | 50,157 |
| 49,822 |
| 38,641 |
| 142,732 |
| 109,194 |
| Net cash provided by operating activities | 323,575 |
| 223,694 |
| 313,917 |
| 845,485 |
| 803,208 |
| Purchases of property, plant and equipment and software | 34,138 |
| 33,641 |
| 20,270 |
| 96,980 |
| 60,803 |
| Payment of dividends to stockholders | 92,931 |
| 93,484 |
| 91,108 |
| 280,376 |
| 272,860 |
| Repurchases of common stock | 260,939 |
| 32,250 |
| 1,015 |
| 738,184 |
| 161,551 |
| Taxes paid related to net share settlement of restricted stock units, net of proceeds from issuance of common stock | 3,565 |
| 47,857 |
| 2,515 |
| 55,541 |
| 23,593 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STOCK-BASED COMPENSATION INCLUDED IN: |
|
|
|
|
|
|
|
|
|
| Cost of revenues | $ 2,961 |
| $ 2,812 |
| $ 2,366 |
| $ 8,386 |
| $ 6,650 |
| Research and development | 31,543 |
| 29,702 |
| 22,352 |
| 86,119 |
| 63,329 |
| Selling, general and administrative | 15,653 |
| 17,308 |
| 13,923 |
| 48,227 |
| 39,215 |
